Description

MicroarrayPanel:Livercancer-metastasis-normalNo.ofsamples59No.ofpatients44Corediameter2.0mmFormat:FormalinFixedSectionthickness4micrometer Core#No. Age Sex Organ Diagnosis pTNM Stage Months* Tissuetype Image 1 41 M Liver hepatocellularcarcinoma T3aN0M0 IIIA . 6 "class="fd_image"> 2 52 M Liver hepatocellularcarcinoma T3aN0M0 IIIA . 6 "class="fd_image"> 3 56 M Liver hepatocellularcarcinoma T1N0M0 I . 6 "class="fd_image"> 4 37 M Liver hepatocellularcarcinoma T4NxM1 IVB . 6 "class="fd_image"> 5 32 M Liver combinedhepatocellularcarcinoma&cholangiocarcinoma T3aN0M0 IIIA . 6 "class="fd_image"> 6 57 M Liver hepatocellularcarcinoma T3aN0M0 IIIA . 6 "class="fd_image"> 7 65 M Liver hepatocellularcarcinoma,moderatelydifferentiated T1N0M0 I . 6 "class="fd_image"> 8 72 M Liver hepatocellularcarcinoma,welldifferentiated&poorlydifferentiated T2N0M0 II . 6 "class="fd_image"> 9 58 F Liver hepatocellularcarcinoma,welldifferentiated T2N0M0 II . 6 "class="fd_image"> 10 52 M Liver hepatocellularcarcinoma,welldifferentiated T2N0M0 II . 6 "class="fd_image"> 11 40 M Liver hepatocellularcarcinoma,moderatelydifferentiated T2N0M0 II . 6 "class="fd_image"> 12 67 M Liver hepatocellularcarcinoma,moderatelydifferentiated T2N0M0 II . 6 "class="fd_image"> 13 20 M Liver hepatocellularcarcinoma,welldifferentiated T4N0M0 IIIC . 6 "class="fd_image"> 14 48 M Liver hepatocellularcarcinoma,moderatelydifferentiated T2N0M0 II . 6 "class="fd_image"> 15 47 M Liver hepatocellularcarcinoma T1N0M0 I . 6 "class="fd_image"> 16 69 F Liver hepatocellularcarcinoma,moderatelydifferentiated T1N0M0 I . 6 "class="fd_image"> 17 63 F Liver hepatocellularcarcinoma,moderatelydifferentiated T1N0M0 I . 6 "class="fd_image"> 18 60 F Liver hepatocellularcarcinoma,poorlydifferentiated T1N0M0 I . 6 "class="fd_image"> 19 66 F Liver hepatocellularcarcinoma,welldifferentiated T2N0M0 II . 6 "class="fd_image"> 20 64 M Liver hepatocellularcarcinoma,poorlydifferentiated T3bN0M0 IIIB . 6 "class="fd_image"> 21 64 M Liver hepatocellularcarcinoma,moderatelydifferentiated T1N0M0 I . 6 "class="fd_image"> 22 54 M Liver hepatocellularcarcinoma,moderatelydifferentiated T3bN0M0 IIIB . 6 "class="fd_image"> 23 65 F Liver hepatocellularcarcinoma,moderatelydifferentiated T1N0M0 I . 6 "class="fd_image"> 24 41 M Liver hepatocellularcarcinoma,moderatelydifferentiated T1N0M0 I . 6 "class="fd_image"> 25 57 F Liver hepatocellularcarcinoma,welldifferentiated T1N0M0 I . 6 "class="fd_image"> 26 57 M Liver hepatocellularcarcinoma,moderatelydifferentiated T3bN0M0 IIIB . 6 "class="fd_image"> 27 50 M Liver hepatocellularpcarcinoma,,poorlyydifferentiated T1N0M0 I . 6 "class="fd_image"> 28 43 M Liver hepatocellularcarcinoma,moderatelydifferentiated T1N0M0 I . 6 "class="fd_image"> 29 60 F Liver hepatocellularcarcinoma,poorlydifferentiated T4N0M0 IIIC . 6 "class="fd_image"> 30 64 M Liver hepatocellularcarcinoma,moderatelydifferentiated T3bN0M0 IIIB . 6 "class="fd_image"> 31 52 M Liver hepatocellularcarcinoma,moderatelydifferentiated T3bN0M0 IIIB . 6 "class="fd_image"> 32 54 M Liver hepatocellularcarcinoma,moderatelydifferentiated T3aN0M0 IIIA . 6 "class="fd_image"> 33 56 M Liver hepatocellularcarcinoma,welldifferentiated T1N0M0 I . 6 "class="fd_image"> 34 77 M Liver hepatocellularcarcinoma,moderatelydifferentiated T2N0M0 II . 6 "class="fd_image"> 35 38 M Liver hepatocellularcarcinoma T2N0M0 II . 6 "class="fd_image"> 36 75 M Liver hepatocellularcarcinoma,moderatelydifferentiated T2N0M1 IVB . 6 "class="fd_image"> 37 43 M Liver hepatocellularcarcinoma,moderatelydifferentiated T3aN0M0 IIIA . 6 "class="fd_image"> 38 72 M Liver hepatocellularcarcinoma,moderatelydifferentiated T4N1M0 IVA . 6 "class="fd_image"> 39 60 F Liver cholangiocarcinoma T1N0M0 I . 6 "class="fd_image"> 40 58 M Liver cholangiocarcinoma T2N1M0 IVA . 6 "class="fd_image"> 41 51 M Colon metastatichepatocellularcarcinoma TxNxM1 IVB . 6 "class="fd_image"> 42 62 M Lung metastatichepatocellularcarcinoma TxNxM1 IVB . 6 "class="fd_image"> 43 61 M Lung metastatichepatocellularcarcinoma TxNxM1 IVB . 6 "class="fd_image"> 44 60 M Adrenalgland metastatichepatocellularcarcinoma TxNxM1 IVB . 6 "class="fd_image"> 45 39 M Lumbarvertebra metastatichepatocellularcarcinomafrom#35 TxNxM1 IVB 22 6 "class="fd_image"> 46 75 M Colon metastatichepatocellularcarcinomafrom#36 T2N0M1 IVB 0 6 "class="fd_image"> 47 43 M Softtissue metastatichepatocellularcarcinomafrom#37 TXNXM1 IVB 5 6 "class="fd_image"> 48 72 M Lymphnode metastatichepatocellularcarcinomafrom#38 T4N1M0 IVA 0 6 "class="fd_image"> 49 60 F Softtissue metastaticcholangiocarcinomafrom#39 TXNXM1 IVB 16 6 "class="fd_image"> 50 58 M Lymphnode metastaticcholangiocarcinomafrom#40 T2N1M0 IVA 0 6 "class="fd_image"> 51 57 M Liver non-neoplasticliver(adjacenttocancer,matchof#6) . . . 3 "class="fd_image"> 52 72 M Liver non-neoplasticliver(adjacenttocancer,matchof#8) . . . 3 "class="fd_image"> 53 58 F Liver non-neoplasticliver(adjacenttocancer,matchof#9) . . . 3 "class="fd_image"> 54 52 M Liver non-neoplasticliver(adjacenttocancer,matchof#10) . . . 3 "class="fd_image"> 55 67 M Liver non-neoplasticliver(adjacenttocancer,matchof#12) . . . 3 "class="fd_image"> 56 32 M Liver non-neoplasticliver(apartfromcancer,matchof#5) . . . 3 "class="fd_image"> 57 63 F Liver non-neoplasticliver(apartfromcancer,matchof#17) . . . 3 "class="fd_image"> 58 65 F Liver non-neoplasticliver(apartfromcancer,matchof#23) . . . 3 "class="fd_image"> 59 57 F Liver non-neoplasticliver(apartfromcancer,matchof#25) . . . 3 "class="fd_image"> 60 . . Carbon . . . . .

ApplicationNotes	Useinmicroarrayreportedinscientificliterature(PMID:28878246).
Publications	ReadPublicationsusingNBP2-30221inthefollowingapplications: IHC 1publication IHC-P 8publications MiAr 2publications

Novus Biologicals北京代理，Novus Biologicals中国代理，Novus Biologicals上海代理，Novus Biologicals公司，Novus Biologicals 【详细说明】  Novus Biologicals北京代理，Novus Biologicals中国代理，Novus Biologicals上海代理，Novus Biologicals公司，Novus Biologicals 上海普迈生物科技有限公司签约代理      欢迎下载下面的资料以了解此产品的相关信息！预询产品订购信息  上海普迈生物致力于提供zui高质量的产品和服务组织形态学研究与竞争力的产品 产品和服务,有相关产品的问题请直接 期货每周下午5点前发定单，正常到上海时间为3-4周 现市区2天内送到，外地以快递为准 敬请关注！ ：   :www.pumaibio.com :pumaibio :（直接客户） （经销商） 促销etonbio、polysciences、Mattek、trevigen、Chromogenix、cyguns、IrvineScientific、Innovative Cell Technologies、enzo、novus、immunochemistry、eylabs、Polyplus、NIBSC、ALZET、hitobiotec、sutter instrument、mirus、StressMarq、Avanti、jena bioscience、Neuro Probe、tedpella、avanti、Rockland、CAYMAN、transgenomic、BioLegend、ambion、omicronbio、 Assaybiotech、chondrex、lc?laboratories、cosmobio、megazyme、NeoMarkers、BTI、eylabs、berryassoc、cellagentech、TOCRIS、Relia Tech、SouthernBiotech、Biosearch technology、Lumiprobe、StemCells?Inc、biovendor、NORGEN、alomone、jena?bioscience、Gracebio、Eurogentec、Gelcompany?、invitrogen、gene?bridges、MRC-Holland、laysanbio